Summary Targovax AS (Targovax) is a pharmaceutical company that offers development of vaccines in the field of oncology. The companys pipeline products include anti-cancer immunotherapy for treatment of indications with unmet medical needs. Its product portfolio includes TG01 is under phase II clinical study is used for the treatment of pancreas cancer; TG02 is under preclinical study is for the treatment of lung and colorectal cancer; and TG03 is under preclinical study and used for the treatment of malignant melanoma. The company develops active immunotherapy in the form of cancer vaccines. Targovax is headquartered in Lysaker, Norway. Targovax AS Pharmaceuticals & Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived... Research Beam Model: Research Beam Product ID: 663107 250 USD New
Targovax AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Targovax AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : May   2016
  • Pages : 23
  • Publisher : GlobalData
 
 
 
Summary

Targovax AS (Targovax) is a pharmaceutical company that offers development of vaccines in the field of oncology. The companys pipeline products include anti-cancer immunotherapy for treatment of indications with unmet medical needs. Its product portfolio includes TG01 is under phase II clinical study is used for the treatment of pancreas cancer; TG02 is under preclinical study is for the treatment of lung and colorectal cancer; and TG03 is under preclinical study and used for the treatment of malignant melanoma. The company develops active immunotherapy in the form of cancer vaccines. Targovax is headquartered in Lysaker, Norway.

Targovax AS Pharmaceuticals & Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
Business Description A brief description of the company's operations.
Key Employees A list of the key executives of the company.
Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors A list of the key competitors of the company.
Key Recent Developments A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Targovax AS, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Targovax AS, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Targovax AS, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Targovax AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Targovax AS, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Targovax AS, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Targovax Raises US$1.3 Million In Venture Financing 10
Targovax Raises US$2.2 Million In Series A Financing 12
Targovax Raises Additional US$1 Million In Venture Financing 13
Oncos Therapeutics Raises US$5.5 Million In Venture Financing 14
Partnerships 15
Ludwig Institute for Cancer Research and Cancer Research Institute Partner with Targovax 15
Merger 16
Oncos Therapeutics Completes Merger with Targovax 16
Equity Offering 17
Targovax to Raise USD26 Million in Private Placement of Shares 17
Targovax Raises USD11.6 Million through Shares Issue 19
Targovax AS - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List Of Tables
List of Tables
Targovax AS, Pharmaceuticals & Healthcare, Key Facts 1
Targovax AS, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Targovax AS, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Targovax AS, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Targovax AS, Deals By Therapy Area, 2010 to YTD 2016 8
Targovax AS, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Targovax Raises US$1.3 Million In Venture Financing 10
Targovax Raises US$2.2 Million In Series A Financing 12
Targovax Raises Additional US$1 Million In Venture Financing 13
Oncos Therapeutics Raises US$5.5 Million In Venture Financing 14
Ludwig Institute for Cancer Research and Cancer Research Institute Partner with Targovax 15
Oncos Therapeutics Completes Merger with Targovax 16
Targovax to Raise USD26 Million in Private Placement of Shares 17
Targovax Raises USD11.6 Million through Shares Issue 19
Targovax AS, Key Competitors 20
Targovax AS, Key Employees 21
Targovax AS, Subsidiaries 22

List Of Figures
List of Figures
Targovax AS, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Targovax AS, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Targovax AS, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Targovax AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Targovax AS, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Targovax AS, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Targovax AS, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Targovax AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter